PUBLISHER: The Business Research Company | PRODUCT CODE: 1668443
PUBLISHER: The Business Research Company | PRODUCT CODE: 1668443
Muscarinic Acetylcholine Receptor Global Market Report 2025
Muscarinic acetylcholine receptors (mAChRs) belong to a class of G protein-coupled receptors (GPCRs) activated by the neurotransmitter acetylcholine. These receptors are widely distributed throughout the body, playing vital roles in numerous physiological processes, particularly within the central and peripheral nervous systems.
The primary types of muscarinic acetylcholine receptors include M1, M4, M5, among others. The M1 subtype is one of the five receptor subtypes involved in mediating the effects of acetylcholine. These receptors are G protein-coupled and participate in various physiological responses to acetylcholine. These receptors are accessible through different distribution channels such as hospitals, clinics, retail pharmacies, online pharmacies, and specialty centers. They find applications in several medical conditions such as chronic obstructive pulmonary disease, attention deficit hyperactivity disorder, Alzheimer's disease, memory impairment, psychiatric disorders, and more.
The muscarinic acetylcholine receptors market research report is one of a series of new reports from The Business Research Company that provides muscarinic acetylcholine receptors market statistics, including muscarinic acetylcholine receptors industry global market size, regional shares, competitors with a muscarinic acetylcholine receptors market share, detailed muscarinic acetylcholine receptors market segments, market trends and opportunities, and any further data you may need to thrive in the muscarinic acetylcholine receptors industry. This muscarinic acetylcholine receptors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The muscarinic acetylcholine receptor market size has grown steadily in recent years. It will grow from$1.82 billion in 2024 to $1.89 billion in 2025 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to neurological disorders treatment, cardiovascular disorders management, ophthalmic disorders therapies, respiratory conditions treatment, gastrointestinal disorders
The muscarinic acetylcholine receptor market size is expected to see strong growth in the next few years. It will grow to $2.37 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to advancements in neuropharmacology, increasing cardiovascular disease cases, innovations in ophthalmic therapeutics, emerging respiratory therapies, expanding gastrointestinal drug pipeline. Major trends in the forecast period include utilization in ophthalmic conditions, strategic partnerships for drug discovery, development of tissue-selective agents, potential in gastrointestinal disorders, focus on personalized treatment approaches.
The rising prevalence of neurological disorders is anticipated to drive the growth of the muscarinic acetylcholine receptor (mAChR) market in the future. Neurological disorders encompass medical conditions that impact the nervous system, including the brain, spinal cord, and peripheral nerves. Muscarinic acetylcholine receptors play a vital role in regulating complex behaviors such as cognition, locomotion, and reward, making them promising therapeutic targets for various neurological conditions. For example, data from the Australian Bureau of Statistics National Health Survey, a government agency in Australia, revealed that the estimated prevalence of heart disease and stroke increased to 5.2% in 2022, affecting 1.3 million individuals, compared to 4.1% in 2001. Consequently, the growing incidence of neurological disorders is fueling the expansion of the muscarinic acetylcholine receptor market.
The growing awareness and diagnosis of glaucoma are expected to significantly boost the muscarinic acetylcholine receptor market. Glaucoma, a progressive eye disease damaging the optic nerve, often associates increased intraocular pressure with muscarinic acetylcholine receptors' role in regulating it. According to the BrightFocus Foundation in October 2022, about 2.7 million out of three million Americans aged 40 or older with glaucoma suffer from open-angle glaucoma, the most prevalent type. Globally, the glaucoma population is anticipated to reach over 111 million by 2040 from the current 80 million. This increased understanding of glaucoma's link to muscarinic receptors drives the market growth.
The upsurge in research and development initiatives is a pivotal trend shaping the muscarinic acetylcholine receptor market. Companies in this sector are intensifying development activities to fortify their market position. For example, in January 2022, researchers at Merck introduced MK-6884, a carbon-11-labeled molecule detecting the M4 subtype of muscarinic cholinergic receptors. This innovation aids in measuring drug efficacy and neuropathological receptor loss in conditions such as Alzheimer's disease.
Major companies in the muscarinic acetylcholine receptor market are committed to innovating new products, seeking regulatory approval for schizophrenia treatment. Schizophrenia, a severe mental illness impacting thoughts, feelings, and behavior, often causes individuals to seem detached from reality. For instance, in September 2023, Karuna Therapeutics, Inc. submitted a New Drug Application (NDA) for KarXT (xanomeline-trospium) to the FDA for schizophrenia treatment. The company's dedication lies in pioneering innovative treatments for neurological and psychiatric illnesses, striving to address unmet medical needs.
In August 2024, AbbVie, a pharmaceutical company based in the U.S., acquired Cerevel Therapeutics for an undisclosed sum. This acquisition is part of AbbVie's strategy to enhance its neuroscience portfolio, particularly focusing on treatments for conditions such as schizophrenia, Parkinson's disease, and other neurological disorders. Cerevel Therapeutics, also a U.S.-based company, specializes in developing innovative therapies for neurological diseases, including schizophrenia, epilepsy, and Parkinson's disease, and focuses on creating treatments that target muscarinic acetylcholine receptors.
Major companies operating in the muscarinic acetylcholine receptor market include Heptares Therapeutics Ltd., Sumitomo Dainippon Pharma Co. Ltd., Anavex Life Sciences Corp., NeuroHealing Pharmaceuticals Inc., AstraZeneca plc, Karuna Pharmaceuticals Inc., Anven AlzDx Inc., Merck & Co Inc., Elsevier BV, Eurofins Discover X Corporation, Novus Biologicals LLC, Eli Lilly and Co., Novatein Biosciences Inc., Alomone Labs Ltd., GlaxoSmithKline plc, SK Bioscience Co., Johnson & Johnson, Pfizer Inc., Novartis AG, AbbVie Inc., Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd., Eisai Co. Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Sanofi SA, Sun Pharmaceutical Industries Ltd.
North America was the largest region in the muscarinic acetylcholine receptor market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global muscarinic acetylcholine receptor market during the forecast period. The regions covered in the muscarinic acetylcholine receptor market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the muscarinic acetylcholine receptor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The muscarinic acetylcholine receptors market consists of sales of extracellular N-terminal segment, transmembrane domains (TM1-TM7), intracellular loops (IL1-IL3), intracellular C-terminal segment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Muscarinic Acetylcholine Receptor Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on muscarinic acetylcholine receptor market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for muscarinic acetylcholine receptor ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The muscarinic acetylcholine receptor market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: M1; M4; M5; Other Types
- 2) By Distribution Channel: Hospitals; Clinics; Retail Pharmacies; Online Pharmacies; Specialty Centers
- 3) By Application: Chronic Obstructive Pulmonary Disease; Attention Deficit Hyperactivity Disorder; Alzheimer's Disease; Memory Impairment; Psychiatric Disorders; Other Applications
- Subsegments:
- 1) By M1 Receptor: Centrally Acting Antagonists; Centrally Acting Agonists; Peripherally Acting Compounds
- 2) By M4 Receptor: Selective Agonists; Selective Antagonists; Non-Selective Agents
- 3) By M5 Receptor: Agonists; Antagonists; Other Modulators
- 4) By Other Types: M2 Receptor; M3 Receptor; Combination Receptor Products
- Companies Mentioned: Heptares Therapeutics Ltd.; Sumitomo Dainippon Pharma Co. Ltd.; Anavex Life Sciences Corp.; NeuroHealing Pharmaceuticals Inc.; AstraZeneca plc
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Muscarinic Acetylcholine Receptor Market Characteristics
3. Muscarinic Acetylcholine Receptor Market Trends And Strategies
4. Muscarinic Acetylcholine Receptor Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market
5. Global Muscarinic Acetylcholine Receptor Growth Analysis And Strategic Analysis Framework
- 5.1. Global Muscarinic Acetylcholine Receptor PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Muscarinic Acetylcholine Receptor Market Growth Rate Analysis
- 5.4. Global Muscarinic Acetylcholine Receptor Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Muscarinic Acetylcholine Receptor Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Muscarinic Acetylcholine Receptor Total Addressable Market (TAM)
6. Muscarinic Acetylcholine Receptor Market Segmentation
- 6.1. Global Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- M1
- M4
- M5
- Other Types
- 6.2. Global Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Clinics
- Retail Pharmacies
- Online Pharmacies
- Specialty Centers
- 6.3. Global Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Chronic Obstructive Pulmonary Disease
- Attention Deficit Hyperactivity Disorder
- Alzheimer's Disease
- Memory Impairment
- Psychiatric Disorders
- Other Applications
- 6.4. Global Muscarinic Acetylcholine Receptor Market, Sub-Segmentation Of M1, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Centrally Acting Antagonists
- Centrally Acting Agonists
- Peripherally Acting Compounds
- 6.5. Global Muscarinic Acetylcholine Receptor Market, Sub-Segmentation Of M4, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Selective Agonists
- Selective Antagonists
- Non-Selective Agents
- 6.6. Global Muscarinic Acetylcholine Receptor Market, Sub-Segmentation Of M5, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Agonists
- Antagonists
- Other Modulators
- 6.7. Global Muscarinic Acetylcholine Receptor Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- M2 Receptor
- M3 Receptor
- Combination Receptor Products
7. Muscarinic Acetylcholine Receptor Market Regional And Country Analysis
- 7.1. Global Muscarinic Acetylcholine Receptor Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Muscarinic Acetylcholine Receptor Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Muscarinic Acetylcholine Receptor Market
- 8.1. Asia-Pacific Muscarinic Acetylcholine Receptor Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Muscarinic Acetylcholine Receptor Market
- 9.1. China Muscarinic Acetylcholine Receptor Market Overview
- 9.2. China Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Muscarinic Acetylcholine Receptor Market
- 10.1. India Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Muscarinic Acetylcholine Receptor Market
- 11.1. Japan Muscarinic Acetylcholine Receptor Market Overview
- 11.2. Japan Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Muscarinic Acetylcholine Receptor Market
- 12.1. Australia Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Muscarinic Acetylcholine Receptor Market
- 13.1. Indonesia Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Muscarinic Acetylcholine Receptor Market
- 14.1. South Korea Muscarinic Acetylcholine Receptor Market Overview
- 14.2. South Korea Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Muscarinic Acetylcholine Receptor Market
- 15.1. Western Europe Muscarinic Acetylcholine Receptor Market Overview
- 15.2. Western Europe Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Muscarinic Acetylcholine Receptor Market
- 16.1. UK Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Muscarinic Acetylcholine Receptor Market
- 17.1. Germany Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Muscarinic Acetylcholine Receptor Market
- 18.1. France Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Muscarinic Acetylcholine Receptor Market
- 19.1. Italy Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Muscarinic Acetylcholine Receptor Market
- 20.1. Spain Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Muscarinic Acetylcholine Receptor Market
- 21.1. Eastern Europe Muscarinic Acetylcholine Receptor Market Overview
- 21.2. Eastern Europe Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Muscarinic Acetylcholine Receptor Market
- 22.1. Russia Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Muscarinic Acetylcholine Receptor Market
- 23.1. North America Muscarinic Acetylcholine Receptor Market Overview
- 23.2. North America Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Muscarinic Acetylcholine Receptor Market
- 24.1. USA Muscarinic Acetylcholine Receptor Market Overview
- 24.2. USA Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Muscarinic Acetylcholine Receptor Market
- 25.1. Canada Muscarinic Acetylcholine Receptor Market Overview
- 25.2. Canada Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Muscarinic Acetylcholine Receptor Market
- 26.1. South America Muscarinic Acetylcholine Receptor Market Overview
- 26.2. South America Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Muscarinic Acetylcholine Receptor Market
- 27.1. Brazil Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Muscarinic Acetylcholine Receptor Market
- 28.1. Middle East Muscarinic Acetylcholine Receptor Market Overview
- 28.2. Middle East Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Muscarinic Acetylcholine Receptor Market
- 29.1. Africa Muscarinic Acetylcholine Receptor Market Overview
- 29.2. Africa Muscarinic Acetylcholine Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Muscarinic Acetylcholine Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Muscarinic Acetylcholine Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Muscarinic Acetylcholine Receptor Market Competitive Landscape And Company Profiles
- 30.1. Muscarinic Acetylcholine Receptor Market Competitive Landscape
- 30.2. Muscarinic Acetylcholine Receptor Market Company Profiles
- 30.2.1. Heptares Therapeutics Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Sumitomo Dainippon Pharma Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Anavex Life Sciences Corp. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. NeuroHealing Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
31. Muscarinic Acetylcholine Receptor Market Other Major And Innovative Companies
- 31.1. Karuna Pharmaceuticals Inc.
- 31.2. Anven AlzDx Inc.
- 31.3. Merck & Co Inc.
- 31.4. Elsevier BV
- 31.5. Eurofins Discover X Corporation
- 31.6. Novus Biologicals LLC
- 31.7. Eli Lilly and Co.
- 31.8. Novatein Biosciences Inc.
- 31.9. Alomone Labs Ltd.
- 31.10. GlaxoSmithKline plc
- 31.11. SK Bioscience Co.
- 31.12. Johnson & Johnson
- 31.13. Pfizer Inc.
- 31.14. Novartis AG
- 31.15. AbbVie Inc.
32. Global Muscarinic Acetylcholine Receptor Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Muscarinic Acetylcholine Receptor Market
34. Recent Developments In The Muscarinic Acetylcholine Receptor Market
35. Muscarinic Acetylcholine Receptor Market High Potential Countries, Segments and Strategies
- 35.1 Muscarinic Acetylcholine Receptor Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Muscarinic Acetylcholine Receptor Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Muscarinic Acetylcholine Receptor Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
